| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cargo receptor activity | 3.64e-07 | 85 | 107 | 7 | GO:0038024 | |
| GeneOntologyMolecularFunction | calcium ion binding | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 4.74e-07 | 749 | 107 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.83e-06 | 188 | 107 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 2.84e-05 | 2 | 107 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.96e-05 | 16 | 107 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.69e-04 | 4 | 107 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.85e-04 | 21 | 107 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.95e-04 | 156 | 107 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | integrin binding | 3.62e-04 | 175 | 107 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.98e-04 | 27 | 107 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | neuregulin binding | 4.21e-04 | 6 | 107 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 8.64e-04 | 35 | 107 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 8.64e-04 | 35 | 107 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | structural molecule activity | GPM6B MXRA5 COL19A1 KRT83 COPE LAMA1 LAMA5 EDIL3 FBN1 FBN2 LMNA LTBP2 PLP1 | 9.55e-04 | 891 | 107 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of myelin sheath | 1.52e-03 | 11 | 107 | 2 | GO:0019911 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.81e-03 | 12 | 107 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | histone ubiquitin ligase activity | 1.81e-03 | 12 | 107 | 2 | GO:0140852 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 2.21e-03 | 430 | 107 | 8 | GO:0004175 | |
| GeneOntologyBiologicalProcess | neuron development | GPM6B VLDLR CUX2 DRD1 GLDN NRDC LAMA1 LAMA5 ITGA6 CSMD3 CREBBP LRP8 LHX1 BCL11B BTG2 TENM4 SCARB2 UNC5C ANAPC2 SLIT3 NEUROD6 PLP1 NOTCH2 USP33 | 3.55e-07 | 1463 | 107 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | GPM6B VLDLR CUX2 NRDC LAMA1 LAMA5 ITGA6 CSMD3 CREBBP LRP8 LHX1 BCL11B BTG2 SCARB2 UNC5C ANAPC2 SLIT3 NEUROD6 PLP1 NOTCH2 USP33 | 2.34e-06 | 1285 | 107 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | axon development | GPM6B NRDC LAMA1 LAMA5 LHX1 BCL11B UNC5C ANAPC2 SLIT3 NEUROD6 PLP1 NOTCH2 USP33 | 2.82e-05 | 642 | 107 | 13 | GO:0061564 |
| GeneOntologyCellularComponent | extracellular matrix | MXRA5 COL19A1 ADAMTS4 LAMA1 LAMA5 ITGA6 MUC5B EDIL3 F7 FBN1 FBN2 FCGBP LTBP2 LTBP3 USH2A | 1.25e-06 | 656 | 107 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MXRA5 COL19A1 ADAMTS4 LAMA1 LAMA5 ITGA6 MUC5B EDIL3 F7 FBN1 FBN2 FCGBP LTBP2 LTBP3 USH2A | 1.30e-06 | 658 | 107 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | MXRA5 COL19A1 ADAMTS4 LAMA1 LAMA5 ITGA6 EDIL3 F7 FBN1 FBN2 LTBP2 LTBP3 USH2A | 3.18e-06 | 530 | 107 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | cell surface | VLDLR DRD1 GLDN NRDC ITGA6 TNFRSF10D CUBN ITGB2 F10 CD163 LRP8 SCUBE1 IGF2R CD6 CD8A MRC2 UNC5C CORIN NOTCH2 | 3.30e-06 | 1111 | 107 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | receptor complex | 1.93e-04 | 581 | 107 | 11 | GO:0043235 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.38e-04 | 59 | 107 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.45e-04 | 109 | 107 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | basement membrane | 4.12e-04 | 122 | 107 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | integrin complex | 5.80e-04 | 32 | 107 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | plasma membrane raft | 9.60e-04 | 147 | 107 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | laminin complex | 1.14e-03 | 10 | 107 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.39e-03 | 94 | 107 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | microfibril | 1.95e-03 | 13 | 107 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.01e-03 | 104 | 107 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.17e-03 | 350 | 107 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | membrane raft | 2.61e-03 | 362 | 107 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.70e-03 | 364 | 107 | 7 | GO:0098857 | |
| MousePheno | abnormal left-right axis symmetry of the somites | 1.46e-05 | 8 | 91 | 3 | MP:0005224 | |
| MousePheno | abnormal gastrulation movements | 3.10e-05 | 10 | 91 | 3 | MP:0002174 | |
| MousePheno | abnormal retina blood vessel pattern | 4.24e-05 | 11 | 91 | 3 | MP:0010098 | |
| MousePheno | abnormal cerebellum morphology | VLDLR AARS1 ERBB3 ADAMTS4 ZNF521 LRP8 SACS UNC5C HERC2 CPLANE1 PLP1 | 4.32e-05 | 389 | 91 | 11 | MP:0000849 |
| MousePheno | increased bone mineral content | 4.53e-05 | 258 | 91 | 9 | MP:0010123 | |
| MousePheno | abnormal spinal nerve morphology | 6.87e-05 | 107 | 91 | 6 | MP:0001077 | |
| MousePheno | abnormal hindbrain morphology | VLDLR AARS1 ERBB3 ADAMTS4 ZNF521 LRP8 SCUBE1 SACS UNC5C HERC2 CPLANE1 PLP1 | 6.94e-05 | 485 | 91 | 12 | MP:0000841 |
| MousePheno | atrioventricular valve regurgitation | 7.28e-05 | 13 | 91 | 3 | MP:0006046 | |
| MousePheno | abnormal spinal cord morphology | 8.06e-05 | 278 | 91 | 9 | MP:0000955 | |
| MousePheno | abnormal metencephalon morphology | VLDLR AARS1 ERBB3 ADAMTS4 ZNF521 LRP8 SACS UNC5C HERC2 CPLANE1 PLP1 | 8.62e-05 | 420 | 91 | 11 | MP:0000847 |
| MousePheno | abnormal viscerocranium morphology | ZNF521 LAMA5 CREBBP JAG2 CNNM4 SCUBE1 BCL11B FBN1 FBN2 LMNA LTBP3 CPLANE1 DISP1 | 1.16e-04 | 593 | 91 | 13 | MP:0005274 |
| MousePheno | short maxilla | 1.16e-04 | 39 | 91 | 4 | MP:0000097 | |
| MousePheno | abnormal cerebellar cortex morphology | 1.44e-04 | 300 | 91 | 9 | MP:0004097 | |
| MousePheno | incomplete somite formation | 1.87e-04 | 44 | 91 | 4 | MP:0001689 | |
| Domain | EGF_1 | VLDLR LAMA1 LAMA5 ADAM32 CUBN VWCE EDIL3 ITGB2 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 TENM4 SLIT3 HABP2 LTBP2 LTBP3 USH2A NOTCH2 | 8.51e-23 | 255 | 106 | 24 | PS00022 |
| Domain | EGF | VLDLR LAMA1 LAMA5 ADAM32 CUBN VWCE EDIL3 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 FCGBP TENM4 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 2.97e-22 | 235 | 106 | 23 | SM00181 |
| Domain | EGF-like_dom | VLDLR LAMA1 LAMA5 ADAM32 CUBN VWCE EDIL3 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 FCGBP TENM4 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 1.13e-21 | 249 | 106 | 23 | IPR000742 |
| Domain | EGF-like_CS | VLDLR LAMA1 LAMA5 ADAM32 CUBN VWCE EDIL3 ITGB2 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 TENM4 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 3.32e-21 | 261 | 106 | 23 | IPR013032 |
| Domain | EGF_2 | VLDLR LAMA1 LAMA5 ADAM32 CUBN VWCE EDIL3 ITGB2 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 TENM4 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 4.71e-21 | 265 | 106 | 23 | PS01186 |
| Domain | EGF_CA | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 2.73e-19 | 122 | 106 | 17 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 3.63e-19 | 124 | 106 | 17 | IPR001881 |
| Domain | EGF_3 | VLDLR ADAM32 CUBN VWCE EDIL3 F7 F10 PTGS2 LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 TENM4 SLIT3 HABP2 LTBP2 LTBP3 NOTCH2 | 3.27e-18 | 235 | 106 | 20 | PS50026 |
| Domain | EGF_Ca-bd_CS | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 JAG2 SCUBE1 FBN1 FBN2 SLIT3 LTBP2 LTBP3 NOTCH2 | 7.72e-18 | 97 | 106 | 15 | IPR018097 |
| Domain | EGF_CA | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 JAG2 SCUBE1 FBN1 FBN2 SLIT3 LTBP2 LTBP3 NOTCH2 | 1.06e-17 | 99 | 106 | 15 | PS01187 |
| Domain | Growth_fac_rcpt_ | VLDLR ERBB3 KRT83 LAMA1 LAMA5 CUBN VWCE LRP8 STAB1 JAG2 SCUBE1 FBN1 FBN2 SLIT3 LTBP2 LTBP3 NOTCH2 | 1.99e-17 | 156 | 106 | 17 | IPR009030 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 JAG2 SCUBE1 FBN1 FBN2 SLIT3 LTBP2 LTBP3 NOTCH2 | 3.10e-17 | 106 | 106 | 15 | IPR000152 |
| Domain | ASX_HYDROXYL | VLDLR CUBN VWCE EDIL3 F7 F10 LRP8 JAG2 SCUBE1 FBN1 FBN2 LTBP2 LTBP3 NOTCH2 | 4.38e-16 | 100 | 106 | 14 | PS00010 |
| Domain | EGF | VLDLR CUBN EDIL3 F7 F10 PTGS2 LRP8 STAB1 JAG2 SLIT3 HABP2 LTBP2 NOTCH2 | 2.99e-13 | 126 | 106 | 13 | PF00008 |
| Domain | EGF_CA | VLDLR CUBN VWCE LRP8 JAG2 SCUBE1 FBN1 FBN2 LTBP2 LTBP3 NOTCH2 | 1.99e-12 | 86 | 106 | 11 | PF07645 |
| Domain | TB | 3.39e-08 | 7 | 106 | 4 | PF00683 | |
| Domain | EGF_extracell | 4.68e-08 | 60 | 106 | 7 | IPR013111 | |
| Domain | EGF_2 | 4.68e-08 | 60 | 106 | 7 | PF07974 | |
| Domain | - | 6.74e-08 | 8 | 106 | 4 | 3.90.290.10 | |
| Domain | TB_dom | 1.21e-07 | 9 | 106 | 4 | IPR017878 | |
| Domain | TB | 1.21e-07 | 9 | 106 | 4 | PS51364 | |
| Domain | hEGF | 4.74e-07 | 28 | 106 | 5 | PF12661 | |
| Domain | VWC_out | 3.56e-06 | 19 | 106 | 4 | SM00215 | |
| Domain | cEGF | 1.33e-05 | 26 | 106 | 4 | PF12662 | |
| Domain | cEGF | 1.33e-05 | 26 | 106 | 4 | IPR026823 | |
| Domain | Laminin_G | 1.93e-05 | 58 | 106 | 5 | IPR001791 | |
| Domain | EGF_LAM_2 | 2.40e-05 | 30 | 106 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 2.40e-05 | 30 | 106 | 4 | PS01248 | |
| Domain | EGF_dom | 3.77e-05 | 12 | 106 | 3 | IPR024731 | |
| Domain | EGF_3 | 3.77e-05 | 12 | 106 | 3 | PF12947 | |
| Domain | EGF_Lam | 4.48e-05 | 35 | 106 | 4 | SM00180 | |
| Domain | Laminin_EGF | 4.48e-05 | 35 | 106 | 4 | PF00053 | |
| Domain | VWC | 6.24e-05 | 38 | 106 | 4 | SM00214 | |
| Domain | LAM_G_DOMAIN | 6.24e-05 | 38 | 106 | 4 | PS50025 | |
| Domain | Laminin_EGF | 6.24e-05 | 38 | 106 | 4 | IPR002049 | |
| Domain | Laminin_G_2 | 7.65e-05 | 40 | 106 | 4 | PF02210 | |
| Domain | VWF_dom | 9.29e-05 | 42 | 106 | 4 | IPR001007 | |
| Domain | Laminin_N | 9.43e-05 | 16 | 106 | 3 | IPR008211 | |
| Domain | LamNT | 9.43e-05 | 16 | 106 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 9.43e-05 | 16 | 106 | 3 | PS51117 | |
| Domain | Laminin_N | 9.43e-05 | 16 | 106 | 3 | PF00055 | |
| Domain | MYELIN_PLP_1 | 9.54e-05 | 3 | 106 | 2 | PS00575 | |
| Domain | Myelin_PLP | 9.54e-05 | 3 | 106 | 2 | IPR001614 | |
| Domain | Myelin_PLP_CS | 9.54e-05 | 3 | 106 | 2 | IPR018237 | |
| Domain | Myelin_PLP | 9.54e-05 | 3 | 106 | 2 | PF01275 | |
| Domain | MYELIN_PLP_2 | 9.54e-05 | 3 | 106 | 2 | PS01004 | |
| Domain | PLP | 9.54e-05 | 3 | 106 | 2 | SM00002 | |
| Domain | FBN | 9.54e-05 | 3 | 106 | 2 | IPR011398 | |
| Domain | LamG | 1.12e-04 | 44 | 106 | 4 | SM00282 | |
| Domain | CUB | 1.71e-04 | 49 | 106 | 4 | PF00431 | |
| Domain | CUB | 1.85e-04 | 50 | 106 | 4 | SM00042 | |
| Domain | WWE | 1.90e-04 | 4 | 106 | 2 | SM00678 | |
| Domain | WWE-dom_subgr | 1.90e-04 | 4 | 106 | 2 | IPR018123 | |
| Domain | - | 2.07e-04 | 95 | 106 | 5 | 2.60.120.200 | |
| Domain | - | 2.15e-04 | 52 | 106 | 4 | 2.60.120.290 | |
| Domain | CUB | 2.32e-04 | 53 | 106 | 4 | PS01180 | |
| Domain | CUB_dom | 3.07e-04 | 57 | 106 | 4 | IPR000859 | |
| Domain | Laminin_domII | 3.16e-04 | 5 | 106 | 2 | IPR010307 | |
| Domain | Pept_S1A_FX | 3.16e-04 | 5 | 106 | 2 | IPR012224 | |
| Domain | Laminin_aI | 3.16e-04 | 5 | 106 | 2 | IPR009254 | |
| Domain | Laminin_I | 3.16e-04 | 5 | 106 | 2 | PF06008 | |
| Domain | Laminin_II | 3.16e-04 | 5 | 106 | 2 | PF06009 | |
| Domain | SR | 3.73e-04 | 25 | 106 | 3 | SM00202 | |
| Domain | SRCR-like_dom | 4.20e-04 | 26 | 106 | 3 | IPR017448 | |
| Domain | SRCR_1 | 4.20e-04 | 26 | 106 | 3 | PS00420 | |
| Domain | SRCR_2 | 4.20e-04 | 26 | 106 | 3 | PS50287 | |
| Domain | SRCR | 4.71e-04 | 27 | 106 | 3 | IPR001190 | |
| Domain | Kringle-like | 7.82e-04 | 32 | 106 | 3 | IPR013806 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 8.57e-04 | 33 | 106 | 3 | IPR001368 | |
| Domain | LAMININ_IVA | 8.74e-04 | 8 | 106 | 2 | PS51115 | |
| Domain | Laminin_B | 8.74e-04 | 8 | 106 | 2 | PF00052 | |
| Domain | LamB | 8.74e-04 | 8 | 106 | 2 | SM00281 | |
| Domain | Laminin_IV | 8.74e-04 | 8 | 106 | 2 | IPR000034 | |
| Domain | VWFC_1 | 1.11e-03 | 36 | 106 | 3 | PS01208 | |
| Domain | VWFC_2 | 1.30e-03 | 38 | 106 | 3 | PS50184 | |
| Domain | - | 1.40e-03 | 39 | 106 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.51e-03 | 40 | 106 | 3 | IPR023415 | |
| Domain | TRYPSIN_SER | 1.72e-03 | 90 | 106 | 4 | IPR033116 | |
| Domain | Galactose-bd-like | 2.02e-03 | 94 | 106 | 4 | IPR008979 | |
| Domain | WWE | 2.03e-03 | 12 | 106 | 2 | PF02825 | |
| Domain | WWE-dom | 2.03e-03 | 12 | 106 | 2 | IPR004170 | |
| Domain | Coagulation_fac_subgr_Gla_dom | 2.03e-03 | 12 | 106 | 2 | IPR017857 | |
| Domain | C8 | 2.03e-03 | 12 | 106 | 2 | PF08742 | |
| Domain | WWE | 2.03e-03 | 12 | 106 | 2 | PS50918 | |
| Domain | TIL | 2.03e-03 | 12 | 106 | 2 | PF01826 | |
| Domain | - | 2.03e-03 | 12 | 106 | 2 | 4.10.740.10 | |
| Domain | Ldl_recept_a | 2.12e-03 | 45 | 106 | 3 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.26e-03 | 46 | 106 | 3 | IPR011042 | |
| Domain | - | 2.26e-03 | 46 | 106 | 3 | 4.10.400.10 | |
| Domain | Unchr_dom_Cys-rich | 2.39e-03 | 13 | 106 | 2 | IPR014853 | |
| Domain | C8 | 2.39e-03 | 13 | 106 | 2 | SM00832 | |
| Domain | - | 2.39e-03 | 13 | 106 | 2 | 2.10.10.10 | |
| Domain | LDLRA_1 | 2.55e-03 | 48 | 106 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.71e-03 | 49 | 106 | 3 | IPR002172 | |
| Domain | LDLa | 2.71e-03 | 49 | 106 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.71e-03 | 49 | 106 | 3 | PS50068 | |
| Domain | FN_type2_col-bd | 2.78e-03 | 14 | 106 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.78e-03 | 14 | 106 | 2 | PS51092 | |
| Domain | TIL_dom | 2.78e-03 | 14 | 106 | 2 | IPR002919 | |
| Domain | FN2_1 | 2.78e-03 | 14 | 106 | 2 | PS00023 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL19A1 ADAMTS4 ICAM2 LAMA1 LAMA5 ITGA6 ITGB2 SCUBE1 FBN1 FBN2 LTBP2 LTBP3 | 1.32e-07 | 300 | 81 | 12 | M610 |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.03e-07 | 45 | 81 | 6 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.33e-07 | 46 | 81 | 6 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.65e-07 | 47 | 81 | 6 | M7946 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL19A1 ADAMTS4 ICAM2 ITGA6 ITGB2 SCUBE1 FBN1 FBN2 LTBP2 LTBP3 | 2.12e-06 | 258 | 81 | 10 | MM14572 |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 2.13e-05 | 10 | 81 | 3 | MM14849 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.92e-05 | 11 | 81 | 3 | M158 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.22e-05 | 32 | 81 | 4 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.78e-05 | 37 | 81 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.14e-05 | 39 | 81 | 4 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.15e-04 | 44 | 81 | 4 | M26969 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.37e-04 | 46 | 81 | 4 | M239 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.40e-04 | 18 | 81 | 3 | MM14775 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.52e-04 | 140 | 81 | 6 | M587 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 3.22e-04 | 5 | 81 | 2 | M26948 | |
| Pathway | REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 3.22e-04 | 5 | 81 | 2 | MM14556 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.84e-04 | 25 | 81 | 3 | M39713 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.98e-04 | 114 | 81 | 5 | MM14571 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.56e-04 | 66 | 81 | 4 | M18 | |
| Pathway | PID_INTEGRIN2_PATHWAY | 6.00e-04 | 29 | 81 | 3 | M169 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.63e-04 | 30 | 81 | 3 | M27216 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 6.72e-04 | 7 | 81 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 6.72e-04 | 7 | 81 | 2 | M22049 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 7.32e-04 | 31 | 81 | 3 | M592 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.58e-04 | 74 | 81 | 4 | M616 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 8.81e-04 | 33 | 81 | 3 | M39503 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 8.93e-04 | 8 | 81 | 2 | M47850 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 9.48e-04 | 76 | 81 | 4 | MM14867 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.00e-03 | 133 | 81 | 5 | M16476 | |
| Pathway | REACTOME_TRANSPORT_OF_GAMMA_CARBOXYLATED_PROTEIN_PRECURSORS_FROM_THE_ENDOPLASMIC_RETICULUM_TO_THE_GOLGI_APPARATUS | 1.14e-03 | 9 | 81 | 2 | MM14614 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS | 1.14e-03 | 9 | 81 | 2 | MM14613 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.33e-03 | 38 | 81 | 3 | MM14874 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.38e-03 | 84 | 81 | 4 | M3228 | |
| Pathway | REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS | 1.42e-03 | 10 | 81 | 2 | M26977 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.44e-03 | 39 | 81 | 3 | MM14604 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.44e-03 | 85 | 81 | 4 | M16441 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.52e-03 | 381 | 81 | 8 | M48063 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.73e-03 | 11 | 81 | 2 | M12484 | |
| Pathway | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | 1.73e-03 | 11 | 81 | 2 | MM14615 | |
| Pubmed | 1.11e-08 | 50 | 108 | 6 | 23658023 | ||
| Pubmed | Adamts18 Deficiency Causes Spontaneous SMG Fibrogenesis in Adult Mice. | 1.06e-07 | 37 | 108 | 5 | 34323105 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.60e-07 | 18 | 108 | 4 | 39040056 | |
| Pubmed | A Unique "Reversed" Migration of Neurons in the Developing Claustrum. | 2.90e-07 | 5 | 108 | 3 | 36631266 | |
| Pubmed | 4.10e-07 | 20 | 108 | 4 | 20711475 | ||
| Pubmed | Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. | 5.05e-07 | 21 | 108 | 4 | 23747598 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 5.78e-07 | 6 | 108 | 3 | 18957219 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 15668394 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 1.01e-06 | 7 | 108 | 3 | 9390664 | |
| Pubmed | 1.03e-06 | 106 | 108 | 6 | 18654987 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.25e-06 | 26 | 108 | 4 | 34189436 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 1.46e-06 | 27 | 108 | 4 | 24741061 | |
| Pubmed | 1.61e-06 | 8 | 108 | 3 | 21802298 | ||
| Pubmed | Chromatin regulation by BAF170 controls cerebral cortical size and thickness. | 1.70e-06 | 28 | 108 | 4 | 23643363 | |
| Pubmed | VLDLR AARS1 ERBB3 KRT83 ZNF521 REV3L EDIL3 CREBBP STAB1 FBN1 SACS LTBP3 HERC2 NEUROD6 PLP1 USP33 | 2.29e-06 | 1285 | 108 | 16 | 35914814 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 29912395 | ||
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 2.41e-06 | 9 | 108 | 3 | 30456378 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 2.59e-06 | 31 | 108 | 4 | 31550482 | |
| Pubmed | 3.40e-06 | 130 | 108 | 6 | 19386638 | ||
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 22911783 | ||
| Pubmed | Transcallosal Projections Require Glycoprotein M6-Dependent Neurite Growth and Guidance. | 3.44e-06 | 10 | 108 | 3 | 24917275 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 3.44e-06 | 10 | 108 | 3 | 18590826 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 3.44e-06 | 10 | 108 | 3 | 20976766 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 20809939 | ||
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 3.44e-06 | 10 | 108 | 3 | 16554364 | |
| Pubmed | 4.05e-06 | 134 | 108 | 6 | 19030180 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COPE LAMA1 LAMA5 ITGA6 EDIL3 LRP8 JAG2 FBN1 FBN2 IGF2R MRC2 SCARB2 LTBP2 LTBP3 NOTCH2 | 4.71e-06 | 1201 | 108 | 15 | 35696571 |
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 15465494 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 11381080 | ||
| Pubmed | 6.28e-06 | 12 | 108 | 3 | 10433923 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.50e-06 | 86 | 108 | 5 | 28327460 | |
| Pubmed | 8.14e-06 | 13 | 108 | 3 | 36350252 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 8.14e-06 | 13 | 108 | 3 | 21900571 | |
| Pubmed | 8.37e-06 | 152 | 108 | 6 | 19578796 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12399449 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21851253 | ||
| Pubmed | Oxygen modulates iron homeostasis by switching iron sensing of NCOA4. | 9.55e-06 | 2 | 108 | 2 | 37059186 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 9.55e-06 | 2 | 108 | 2 | 30044367 | |
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 9.55e-06 | 2 | 108 | 2 | 26494287 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 9.55e-06 | 2 | 108 | 2 | 21440062 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15131124 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 25385367 | ||
| Pubmed | The laminin response in inflammatory bowel disease: protection or malignancy? | 9.55e-06 | 2 | 108 | 2 | 25347196 | |
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 9.55e-06 | 2 | 108 | 2 | 20404337 | |
| Pubmed | Factor seven activating protease (FSAP): does it activate factor VII? | 9.55e-06 | 2 | 108 | 2 | 22235940 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 9.55e-06 | 2 | 108 | 2 | 8791520 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26540129 | ||
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 9.55e-06 | 2 | 108 | 2 | 8307578 | |
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 9.55e-06 | 2 | 108 | 2 | 17261317 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22126652 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 9.55e-06 | 2 | 108 | 2 | 7744963 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20019771 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 9.55e-06 | 2 | 108 | 2 | 18006876 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21601501 | ||
| Pubmed | Selective down-regulation of the alpha6-integrin subunit in melanocytes by UVB light. | 9.55e-06 | 2 | 108 | 2 | 15885076 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 9.55e-06 | 2 | 108 | 2 | 24833718 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7798248 | ||
| Pubmed | Residues Y179 and H101 of a hydrophobic patch of factor VII are involved in activation by factor Xa. | 9.55e-06 | 2 | 108 | 2 | 11560488 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16416265 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24265020 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20529844 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23133647 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30306291 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32400230 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30873003 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24637679 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24867584 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 9.55e-06 | 2 | 108 | 2 | 1852206 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16981228 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12429739 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9786897 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28544784 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9602168 | ||
| Pubmed | Notch2-induced COX-2 expression enhancing gastric cancer progression. | 9.55e-06 | 2 | 108 | 2 | 21976141 | |
| Pubmed | Distribution of alpha 6 integrin subunit in developing mouse submandibular gland. | 9.55e-06 | 2 | 108 | 2 | 8409377 | |
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 9.55e-06 | 2 | 108 | 2 | 12524050 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8639673 | ||
| Pubmed | Activation peptides prolong the murine plasma half-life of human factor VII. | 9.55e-06 | 2 | 108 | 2 | 21252090 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 9.55e-06 | 2 | 108 | 2 | 29625025 | |
| Pubmed | Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. | 9.55e-06 | 2 | 108 | 2 | 20048158 | |
| Pubmed | Chromosomal arrangement of the murine coagulation factor VII and factor X genes. | 9.55e-06 | 2 | 108 | 2 | 9759642 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8120105 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35419902 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18301736 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 9.55e-06 | 2 | 108 | 2 | 10504303 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 24720953 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23322581 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19672032 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21621824 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 9.55e-06 | 2 | 108 | 2 | 25524144 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18267072 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 34929721 | ||
| Pubmed | Functional role of laminin α1 chain during cerebellum development. | 9.55e-06 | 2 | 108 | 2 | 22274713 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21737124 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16940506 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 9.55e-06 | 2 | 108 | 2 | 16407178 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10359653 | ||
| Pubmed | Structural genes of coagulation factors VII and X located on 13q34. | 9.55e-06 | 2 | 108 | 2 | 3487272 | |
| Interaction | TMPRSS7 interactions | 4.61e-08 | 8 | 104 | 4 | int:TMPRSS7 | |
| Interaction | FBXO2 interactions | LAMA1 LAMA5 ITGA6 EDIL3 JAG2 FBN1 FBN2 IGF2R MRC2 SPRING1 ANAPC2 IL17RA NOTCH2 | 1.99e-07 | 411 | 104 | 13 | int:FBXO2 |
| Interaction | CORIN interactions | 3.21e-07 | 12 | 104 | 4 | int:CORIN | |
| Interaction | ZNF408 interactions | 8.51e-07 | 145 | 104 | 8 | int:ZNF408 | |
| Interaction | HABP2 interactions | 1.94e-06 | 18 | 104 | 4 | int:HABP2 | |
| Interaction | IGFL3 interactions | 2.46e-06 | 75 | 104 | 6 | int:IGFL3 | |
| Interaction | F7 interactions | 6.57e-06 | 24 | 104 | 4 | int:F7 | |
| Interaction | NTN5 interactions | 6.57e-06 | 24 | 104 | 4 | int:NTN5 | |
| Interaction | TMPRSS6 interactions | 1.56e-05 | 10 | 104 | 3 | int:TMPRSS6 | |
| Interaction | FBN2 interactions | 2.15e-05 | 65 | 104 | 5 | int:FBN2 | |
| Interaction | MFAP2 interactions | 2.84e-05 | 12 | 104 | 3 | int:MFAP2 | |
| Interaction | DTX1 interactions | 3.10e-05 | 35 | 104 | 4 | int:DTX1 | |
| Interaction | ZNF724 interactions | 3.47e-05 | 36 | 104 | 4 | int:ZNF724 | |
| Interaction | LGALS1 interactions | 5.58e-05 | 332 | 104 | 9 | int:LGALS1 | |
| Interaction | F10 interactions | 7.07e-05 | 43 | 104 | 4 | int:F10 | |
| Interaction | ST14 interactions | 9.97e-05 | 207 | 104 | 7 | int:ST14 | |
| Interaction | CCN6 interactions | 1.22e-04 | 19 | 104 | 3 | int:CCN6 | |
| Interaction | ZNF358 interactions | 1.22e-04 | 19 | 104 | 3 | int:ZNF358 | |
| Interaction | FBN1 interactions | 1.39e-04 | 51 | 104 | 4 | int:FBN1 | |
| Interaction | ZNF627 interactions | 1.43e-04 | 20 | 104 | 3 | int:ZNF627 | |
| Interaction | MFAP5 interactions | 1.50e-04 | 52 | 104 | 4 | int:MFAP5 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | ICAM2 ITGA6 TNFRSF10D ITGB2 CD163 IGF2R CD6 CD8A MRC2 IL17RA | 3.04e-06 | 394 | 71 | 10 | 471 |
| GeneFamily | Latent transforming growth factor beta binding proteins | 9.08e-05 | 4 | 71 | 2 | 628 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.59e-04 | 27 | 71 | 3 | 1253 | |
| GeneFamily | Laminin subunits | 9.78e-04 | 12 | 71 | 2 | 626 | |
| GeneFamily | Gla domain containing | 1.15e-03 | 13 | 71 | 2 | 1250 | |
| GeneFamily | Low density lipoprotein receptors | 1.15e-03 | 13 | 71 | 2 | 634 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.23e-03 | 18 | 71 | 2 | 91 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 5.76e-03 | 29 | 71 | 2 | 782 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | MXRA5 GLDN LAMA1 LAMA5 VWCE EDIL3 FBN1 FBN2 SLIT3 LTBP2 LTBP3 USH2A | 3.25e-11 | 196 | 108 | 12 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | MXRA5 GLDN COL19A1 LAMA1 LAMA5 VWCE EDIL3 FBN1 FBN2 SLIT3 LTBP2 LTBP3 USH2A | 1.19e-10 | 275 | 108 | 13 | M5884 |
| Coexpression | NABA_MATRISOME | MXRA5 GLDN COL19A1 ADAMTS4 LAMA1 LAMA5 MUC5B ADAM32 VWCE EDIL3 F7 F10 SCUBE1 FBN1 FBN2 SLIT3 HABP2 LTBP2 LTBP3 USH2A | 6.65e-09 | 1026 | 108 | 20 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.95e-09 | 191 | 108 | 10 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | GLDN COL19A1 LAMA1 LAMA5 VWCE EDIL3 FBN1 FBN2 SLIT3 LTBP2 LTBP3 | 1.61e-08 | 270 | 108 | 11 | MM17057 |
| Coexpression | NABA_MATRISOME | GLDN COL19A1 ADAMTS4 LAMA1 LAMA5 MUC5B ADAM32 VWCE EDIL3 F7 F10 SCUBE1 FBN1 FBN2 SLIT3 HABP2 LTBP2 LTBP3 | 1.55e-07 | 1008 | 108 | 18 | MM17056 |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.39e-06 | 261 | 108 | 9 | M1834 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 2.20e-06 | 205 | 108 | 8 | M39302 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 2.51e-06 | 146 | 108 | 7 | M40222 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | GPM6B DRD1 MXRA5 GLDN EDIL3 SCUBE1 FBN1 TENM4 LMNA GUCY1A2 MRC2 UNC5C SLIT3 LTBP2 | 3.30e-06 | 767 | 108 | 14 | M39209 |
| Coexpression | GROSS_ELK3_TARGETS_DN | 1.02e-05 | 33 | 108 | 4 | M1299 | |
| Coexpression | GROSS_ELK3_TARGETS_DN | 1.29e-05 | 35 | 108 | 4 | MM1124 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.41e-05 | 439 | 108 | 10 | M39054 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP | 1.73e-05 | 196 | 108 | 7 | M9707 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.97e-05 | 200 | 108 | 7 | M5930 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.15e-05 | 385 | 108 | 9 | M39264 | |
| Coexpression | FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS | 4.52e-05 | 311 | 108 | 8 | M61 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.62e-05 | 505 | 108 | 10 | M39167 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 7.91e-05 | 55 | 108 | 4 | MM397 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.24e-04 | 569 | 108 | 10 | M12701 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP | 1.60e-04 | 195 | 108 | 6 | M5318 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN | 1.74e-04 | 198 | 108 | 6 | M7261 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 1.79e-04 | 199 | 108 | 6 | M4494 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP | 1.84e-04 | 200 | 108 | 6 | M4579 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 1.84e-04 | 200 | 108 | 6 | M4016 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 1.84e-04 | 200 | 108 | 6 | M3413 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN | 1.84e-04 | 200 | 108 | 6 | M4955 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 1.84e-04 | 200 | 108 | 6 | M4948 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 1.84e-04 | 200 | 108 | 6 | M4966 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 1.84e-04 | 200 | 108 | 6 | M7500 | |
| Coexpression | GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP | 1.84e-04 | 200 | 108 | 6 | M8703 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS | 2.06e-04 | 130 | 108 | 5 | M40147 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6 | 2.30e-04 | 29 | 108 | 3 | M2412 | |
| Coexpression | SABATES_COLORECTAL_ADENOMA_DN | 2.45e-04 | 299 | 108 | 7 | M14791 | |
| Coexpression | PDGF_UP.V1_DN | 2.54e-04 | 136 | 108 | 5 | M2832 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 2.81e-04 | 630 | 108 | 10 | MM1038 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 3.09e-04 | 32 | 108 | 3 | M5903 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.84e-08 | 65 | 103 | 7 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.88e-08 | 146 | 103 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | LAMA1 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 MRC2 UNC5C | 6.69e-08 | 207 | 103 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | GPM6B GLDN LAMA1 ZNF521 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 MRC2 UNC5C | 1.19e-07 | 418 | 103 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | VLDLR CUX2 LAMA1 ALDH1A2 BTG2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 UNC5C | 1.50e-07 | 354 | 103 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | GPM6B GLDN LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 UNC5C UTY NOTCH2 | 4.60e-07 | 827 | 103 | 17 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | LAMA1 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 UNC5C | 7.43e-07 | 337 | 103 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.49e-06 | 166 | 103 | 8 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.63e-06 | 293 | 103 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.35e-06 | 79 | 103 | 6 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | LAMA1 PTGS2 SCUBE1 ALDH1A2 BTG2 FBN1 TENM4 LMNA GUCY1A2 UNC5C | 2.79e-06 | 311 | 103 | 10 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | GPM6B GLDN LAMA1 ZNF521 OSER1 REV3L PTGS2 SCUBE1 ALDH1A2 BTG2 FBN1 TENM4 LMNA GUCY1A2 UNC5C UTY | 3.21e-06 | 849 | 103 | 16 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | VLDLR CUX2 GLDN LAMA1 PTGS2 LHX1 ALDH1A2 FBN2 TENM4 HABP2 NOTCH2 | 3.72e-06 | 398 | 103 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.35e-06 | 327 | 103 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | GPM6B GLDN LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 FBN1 FBN2 TENM4 GUCY1A2 MRC2 UNC5C UTY NOTCH2 | 4.38e-06 | 768 | 103 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | GPM6B LAMA1 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 DTX4 UNC5C NOTCH2 | 4.74e-06 | 773 | 103 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPM6B LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 DTX4 UNC5C NOTCH2 | 5.04e-06 | 777 | 103 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | GPM6B LAMA1 ZNF521 ITGA6 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 MRC2 UNC5C NOTCH2 | 5.53e-06 | 783 | 103 | 15 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.74e-06 | 199 | 103 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.79e-06 | 265 | 103 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPM6B GLDN LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 TENM4 GUCY1A2 DTX4 SCARB2 UNC5C NOTCH2 | 6.44e-06 | 793 | 103 | 15 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | VLDLR CUX2 LAMA1 LAMA5 CUBN EDIL3 LHX1 BTG2 FBN1 IGF2R GUCY1A2 SCARB2 SLIT3 CORIN HABP2 NOTCH2 | 7.20e-06 | 905 | 103 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 7.85e-06 | 148 | 103 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | GPM6B GLDN LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 FBN1 TENM4 NOTCH2 | 1.11e-05 | 364 | 103 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | GPM6B VLDLR CUX2 LAMA1 ZNF521 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 IGF2R TENM4 GUCY1A2 MRC2 UNC5C | 1.12e-05 | 831 | 103 | 15 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | LAMA1 ZNF521 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 TENM4 SCARB2 UNC5C | 1.37e-05 | 373 | 103 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.60e-05 | 165 | 103 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | LAMA1 ZNF521 ITGA6 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 | 1.93e-05 | 388 | 103 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | VLDLR MXRA5 PCBP3 LAMA1 CSMD3 F7 F10 CD163 LHX1 BTG2 FBN2 TENM4 MRC2 LTBP2 IL17RA LTBP3 | 1.98e-05 | 982 | 103 | 16 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.02e-05 | 310 | 103 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 2.17e-05 | 116 | 103 | 6 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.24e-05 | 240 | 103 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | VLDLR CUX2 GLDN LAMA1 LAMA5 PTGS2 LHX1 ALDH1A2 FBN1 FBN2 TENM4 CORIN HABP2 NOTCH2 | 2.52e-05 | 783 | 103 | 14 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.88e-05 | 122 | 103 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_500 | 3.21e-05 | 412 | 103 | 10 | gudmap_kidney_e15.5_Podocyte_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | CUX2 ZNF521 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 UNC5C | 4.01e-05 | 423 | 103 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.07e-05 | 261 | 103 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | VLDLR CUX2 PCBP3 ICAM2 CSMD3 ALDH1A2 FBN1 FBN2 IGF2R UNC5C SLIT3 CPLANE1 DISP1 | 5.53e-05 | 734 | 103 | 13 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 5.82e-05 | 202 | 103 | 7 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | VLDLR LAMA5 CUBN EDIL3 FBN1 GUCY1A2 SLIT3 CORIN HABP2 NOTCH2 | 7.51e-05 | 456 | 103 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 7.99e-05 | 370 | 103 | 9 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 8.49e-05 | 148 | 103 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.08e-04 | 385 | 103 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.10e-04 | 155 | 103 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | GPM6B LAMA1 ZNF521 ITGA6 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 UNC5C PLP1 | 1.26e-04 | 797 | 103 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | 1.29e-04 | 394 | 103 | 9 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.81e-04 | 58 | 103 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.83e-04 | 108 | 103 | 5 | gudmap_kidney_e15.5_Podocyte_MafB_k3_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 2.12e-04 | 175 | 103 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.35e-04 | 62 | 103 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | GPM6B LAMA1 ZNF521 ITGA6 REV3L SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 | 2.47e-04 | 740 | 103 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | LAMA1 ZNF521 OSER1 PTGS2 SCUBE1 ALDH1A2 BTG2 FBN1 TENM4 LMNA GUCY1A2 MRC2 UNC5C | 2.60e-04 | 858 | 103 | 13 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 2.73e-04 | 436 | 103 | 9 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 3.44e-04 | 356 | 103 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_100 | 3.45e-04 | 6 | 103 | 2 | gudmap_developingKidney_e11.5_ureteric bud_100_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 3.50e-04 | 357 | 103 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.60e-04 | 125 | 103 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | GPM6B VLDLR CUX2 AOX1 REV3L BCL11B FBN2 IGF2R LMNA UNC5C CPLANE1 PHF10 | 3.62e-04 | 772 | 103 | 12 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.77e-04 | 361 | 103 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.47e-04 | 131 | 103 | 5 | ratio_MESO_vs_SC_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | LAMA1 ZNF521 ITGA6 PTGS2 SCUBE1 ALDH1A2 BTG2 FBN1 FBN2 TENM4 GUCY1A2 UNC5C | 4.81e-04 | 797 | 103 | 12 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | VLDLR G2E3 CREBBP PTGS2 LHX1 ALDH1A2 LMNA DTX4 SLIT3 LTBP2 CPLANE1 UTY | 4.92e-04 | 799 | 103 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 5.12e-04 | 76 | 103 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 5.45e-04 | 291 | 103 | 7 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 5.95e-04 | 34 | 103 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | VLDLR CUX2 DTX3L REV3L EDIL3 CSMD3 CREBBP LRP8 BCL11B CELF1 HERC2 CPLANE1 | 6.06e-04 | 818 | 103 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_100 | 6.48e-04 | 35 | 103 | 3 | gudmap_kidney_P3_CapMes_Crym_k1_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.92e-04 | 303 | 103 | 7 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k1 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 7.78e-04 | 148 | 103 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.02e-04 | 230 | 103 | 6 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_100 | 9.29e-04 | 89 | 103 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 9.57e-04 | 155 | 103 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-03 | 91 | 103 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 1.09e-03 | 93 | 103 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 1.11e-03 | 42 | 103 | 3 | gudmap_kidney_e15.5_Podocyte_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000 | ADAMTS4 ICAM2 ITGA6 DTX3L ITGB2 CD163 STAB1 BTG2 SACS IL17RA HERC2 | 1.16e-03 | 761 | 103 | 11 | gudmap_developingKidney_e15.5_Endothelial cells_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.26e-03 | 336 | 103 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.26e-03 | 165 | 103 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 1.30e-03 | 166 | 103 | 5 | gudmap_kidney_e15.5_Podocyte_MafB_k1_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 1.33e-03 | 98 | 103 | 4 | gudmap_kidney_P2_CapMes_Crym_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 1.33e-03 | 98 | 103 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_200 | 1.37e-03 | 168 | 103 | 5 | gudmap_kidney_e15.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.43e-03 | 100 | 103 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | VLDLR CUX2 PCBP3 COPE CSMD3 SCUBE1 ALDH1A2 FBN1 FBN2 UNC5C ANAPC2 SLIT3 | 1.44e-03 | 904 | 103 | 12 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.46e-03 | 445 | 103 | 8 | GSM777043_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | GPM6B ZNF521 LRP8 STAB1 FBN1 FBN2 TENM4 LMNA MRC2 UNC5C SLIT3 CPLANE1 PLP1 UTY | 1.49e-03 | 1166 | 103 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K2 | 1.66e-03 | 104 | 103 | 4 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.66e-03 | 104 | 103 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | MXRA5 ADAMTS4 ZNF521 CSMD2 FBN1 TENM4 GUCY1A2 UNC5C SLIT3 LTBP2 | 4.72e-11 | 194 | 108 | 10 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.49e-11 | 197 | 108 | 10 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.64e-10 | 190 | 108 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-09 | 198 | 108 | 9 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-09 | 198 | 108 | 9 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-09 | 200 | 108 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.47e-08 | 181 | 108 | 8 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-08 | 189 | 108 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-08 | 192 | 108 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-08 | 192 | 108 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-08 | 192 | 108 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-08 | 192 | 108 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-08 | 192 | 108 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-08 | 193 | 108 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-08 | 195 | 108 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-08 | 195 | 108 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-08 | 195 | 108 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-08 | 195 | 108 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-08 | 199 | 108 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.19e-08 | 200 | 108 | 8 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-07 | 161 | 108 | 7 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.89e-07 | 169 | 108 | 7 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.39e-07 | 175 | 108 | 7 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.48e-07 | 185 | 108 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-07 | 186 | 108 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.61e-07 | 186 | 108 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-07 | 189 | 108 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-07 | 190 | 108 | 7 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-07 | 190 | 108 | 7 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-07 | 190 | 108 | 7 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-07 | 191 | 108 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-07 | 192 | 108 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.64e-07 | 193 | 108 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.80e-07 | 194 | 108 | 7 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-07 | 194 | 108 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 4.80e-07 | 194 | 108 | 7 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-07 | 194 | 108 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.97e-07 | 195 | 108 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-07 | 195 | 108 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-07 | 196 | 108 | 7 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-07 | 196 | 108 | 7 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.14e-07 | 196 | 108 | 7 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.32e-07 | 197 | 108 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.32e-07 | 197 | 108 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.32e-07 | 197 | 108 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-07 | 197 | 108 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.32e-07 | 197 | 108 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-07 | 197 | 108 | 7 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.51e-07 | 198 | 108 | 7 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.51e-07 | 198 | 108 | 7 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 5.51e-07 | 198 | 108 | 7 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.70e-07 | 199 | 108 | 7 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.70e-07 | 199 | 108 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 5.70e-07 | 199 | 108 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.70e-07 | 199 | 108 | 7 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 199 | 108 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | 20f760d92c351a1dac4cc0a424c443ea03a179fe | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.70e-07 | 199 | 108 | 7 | 7c272a1aa7f3e931ad5d20809719d85b3bce4cb0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.70e-07 | 199 | 108 | 7 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.70e-07 | 199 | 108 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.89e-07 | 200 | 108 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.89e-07 | 200 | 108 | 7 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | bb605b373caf3f873dc1b87d712704568e0d6040 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.89e-07 | 200 | 108 | 7 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 5.89e-07 | 200 | 108 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.46e-06 | 168 | 108 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 169 | 108 | 6 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 169 | 108 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.10e-06 | 173 | 108 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.52e-06 | 176 | 108 | 6 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | -Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.99e-06 | 179 | 108 | 6 | e4224b2e9c4ae7da62cf670adf811f4112c7d060 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 180 | 108 | 6 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 180 | 108 | 6 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 181 | 108 | 6 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 181 | 108 | 6 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-06 | 181 | 108 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.48e-06 | 182 | 108 | 6 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.66e-06 | 183 | 108 | 6 | 62f76907e501bba6e1010b5c447faed5f0ef93a7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 185 | 108 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 185 | 108 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-06 | 185 | 108 | 6 | 0acd8717ffbfb219664452a0947427eaa8b2a62a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.21e-06 | 186 | 108 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.21e-06 | 186 | 108 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.21e-06 | 186 | 108 | 6 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 186 | 108 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| Disease | interleukin 12 measurement | 1.30e-06 | 53 | 105 | 5 | EFO_0004753 | |
| Disease | Schizophrenia | VLDLR ERBB3 DRD1 LAMA1 CSMD2 PTGS2 CD163 LRP8 JAG2 ALDH1A2 TENM4 UNC5C SLIT3 PLP1 | 3.07e-06 | 883 | 105 | 14 | C0036341 |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.51e-06 | 195 | 105 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 3.75e-05 | 3 | 105 | 2 | C0265313 | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.75e-05 | 3 | 105 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 3.75e-05 | 3 | 105 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 3.75e-05 | 3 | 105 | 2 | C1869114 | |
| Disease | depressive disorder (implicated_via_orthology) | 6.42e-05 | 22 | 105 | 3 | DOID:1596 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 7.49e-05 | 4 | 105 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 7.49e-05 | 4 | 105 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 7.49e-05 | 4 | 105 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | L lactate dehydrogenase measurement | 1.07e-04 | 26 | 105 | 3 | EFO_0004808 | |
| Disease | Geleophysic dysplasia | 1.25e-04 | 5 | 105 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.25e-04 | 5 | 105 | 2 | C0265287 | |
| Disease | response to bronchodilator, response to corticosteroid | 1.25e-04 | 5 | 105 | 2 | GO_0031960, GO_0097366 | |
| Disease | Hyperglycemia, Postprandial | 1.66e-04 | 30 | 105 | 3 | C1855520 | |
| Disease | Hyperglycemia | 1.66e-04 | 30 | 105 | 3 | C0020456 | |
| Disease | Alzheimer disease, age at onset | 2.32e-04 | 343 | 105 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.60e-04 | 7 | 105 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | cholesteryl ester 16:2 measurement | 2.60e-04 | 7 | 105 | 2 | EFO_0021435 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 3.46e-04 | 8 | 105 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | post-operative acute kidney injury | 4.44e-04 | 9 | 105 | 2 | EFO_0009955 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 4.44e-04 | 9 | 105 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | intraocular pressure measurement | 4.79e-04 | 509 | 105 | 8 | EFO_0004695 | |
| Disease | Asthma, Occupational | 5.54e-04 | 10 | 105 | 2 | C0264423 | |
| Disease | coagulation factor XA measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0020266 | |
| Disease | Marfan Syndrome | 6.76e-04 | 11 | 105 | 2 | C0024796 | |
| Disease | Mitral valve prolapse, response to surgery | 8.09e-04 | 12 | 105 | 2 | EFO_0009951, HP_0001634 | |
| Disease | hair colour measurement, hair morphology measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | stenosing tenosynovitis | 8.09e-04 | 12 | 105 | 2 | EFO_0010822 | |
| Disease | dementia (is_implicated_in) | 8.09e-04 | 12 | 105 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | central corneal thickness | 8.49e-04 | 309 | 105 | 6 | EFO_0005213 | |
| Disease | Colorectal Carcinoma | 9.16e-04 | 702 | 105 | 9 | C0009402 | |
| Disease | coagulation factor X measurement | 9.54e-04 | 13 | 105 | 2 | EFO_0020265 | |
| Disease | – | 9.54e-04 | 13 | 105 | 2 | 608446 | |
| Disease | Myocardial infarction, susceptibility to | 9.54e-04 | 13 | 105 | 2 | cv:C1832662 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 9.64e-04 | 122 | 105 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | corneal resistance factor | 1.17e-03 | 451 | 105 | 7 | EFO_0010067 | |
| Disease | Malignant neoplasm of skin | 1.23e-03 | 59 | 105 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 1.23e-03 | 59 | 105 | 3 | C0037286 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.28e-03 | 15 | 105 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.28e-03 | 15 | 105 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.28e-03 | 15 | 105 | 2 | C0154091 | |
| Disease | pulse pressure measurement | CUX2 MXRA5 PCBP3 ANKUB1 LAMA5 FBN1 FBN2 TENM4 CELF1 MRC2 SLIT3 LTBP2 LTBP3 | 1.34e-03 | 1392 | 105 | 13 | EFO_0005763 |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.48e-03 | 137 | 105 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | Bladder Neoplasm | 1.60e-03 | 140 | 105 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.64e-03 | 141 | 105 | 4 | C0005684 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.82e-03 | 145 | 105 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Carcinoma of bladder | 1.85e-03 | 18 | 105 | 2 | C0699885 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.85e-03 | 18 | 105 | 2 | C0751779 | |
| Disease | anorectal malformation | 2.06e-03 | 19 | 105 | 2 | MONDO_0019938 | |
| Disease | glaucoma | 2.27e-03 | 154 | 105 | 4 | MONDO_0005041 | |
| Disease | coagulation factor measurement | 2.29e-03 | 20 | 105 | 2 | EFO_0004634 | |
| Disease | prothrombin time measurement | 2.52e-03 | 21 | 105 | 2 | EFO_0008390 | |
| Disease | Manic | 2.74e-03 | 78 | 105 | 3 | C0338831 | |
| Disease | age of onset of asthma | 2.85e-03 | 79 | 105 | 3 | OBA_2001001 | |
| Disease | alcoholic liver disease | 3.16e-03 | 82 | 105 | 3 | EFO_0008573 | |
| Disease | Hodgkins lymphoma | 3.16e-03 | 82 | 105 | 3 | EFO_0000183 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 3.29e-03 | 24 | 105 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 3.29e-03 | 24 | 105 | 2 | C0887833 | |
| Disease | prostate cancer, disease progression measurement | 3.29e-03 | 24 | 105 | 2 | EFO_0008336, MONDO_0008315 | |
| Disease | Parkinson Disease | 3.50e-03 | 85 | 105 | 3 | C0030567 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKGPELQDCLGQTLV | 621 | P21860 | |
| TGTQCLVSCRSPGLQ | 911 | Q9HCE6 | |
| LQSPLCAGCSSDKQQ | 216 | Q9UJX6 | |
| CQALSCGLPEAPKNG | 2526 | Q7Z408 | |
| ACQAISCGIPKAPTN | 2626 | Q7Z407 | |
| LCCGNTVVIKPAEQT | 201 | O94788 | |
| RSQNPPQSKGCCFVT | 51 | Q92879 | |
| CKPQQKGLRLLCGSQ | 116 | Q6NTF7 | |
| KTNGGCPVCKQLIAL | 1811 | Q92793 | |
| KCSPTLLLLNGQAAC | 211 | O14579 | |
| VDLCNSTKGICLTGP | 126 | Q6ZMI3 | |
| CGPDITLINGLSCKN | 471 | Q8TC27 | |
| LKCQVLLSNPTSGCS | 41 | P01732 | |
| CQTTTGNGKPVECSQ | 241 | P21728 | |
| LACCSPQGPSGDKVN | 276 | O14529 | |
| GNKDGSLQCPTCKTI | 456 | Q9Y2E6 | |
| TRTKVSPNGCLQLNG | 46 | Q96F81 | |
| VGPATICAKNSCQKL | 466 | Q06278 | |
| SVSVQCKPLPCDAQG | 5441 | Q9HC84 | |
| TSGKQNPTGRCKICC | 531 | Q96DM1 | |
| SPGIQEDCCVQLLGK | 21 | Q8HWS3 | |
| PSEAKVLCQSLGCGT | 296 | P30203 | |
| TGKNCQTVLAPCSPN | 826 | Q04721 | |
| CPLGYTGKNCQTLVN | 1051 | Q04721 | |
| LVCSQPGLNCTVKNS | 41 | Q96F46 | |
| VLCGTCGQPADKASA | 586 | P02545 | |
| IVQLKLQGSCTSCPS | 201 | Q9UMS0 | |
| GNKDGSLQCPSCKTI | 461 | Q86UW9 | |
| GICESSGKQCLPLVQ | 996 | O95714 | |
| KNSSCLPNPCVNGGT | 751 | Q9Y219 | |
| PNGICTKCQPSAITL | 201 | Q8TAT6 | |
| GDSCLGINPKKQCIS | 191 | Q9H7Z3 | |
| CNQSLPSICKKAGQL | 496 | Q9UBG0 | |
| QSLICNNVKGCPFTS | 551 | P35354 | |
| TKCAGCAQGISPSDL | 61 | P48742 | |
| TACGAPSGICLQVKS | 526 | P23229 | |
| NVQGPKCDQCSLGTF | 1601 | O15230 | |
| PGKICGSALENICNT | 201 | Q13491 | |
| GCKCGRATQNPSVLT | 461 | Q9HCI7 | |
| SGTPDAIIQCVKQIC | 181 | P57721 | |
| LVKTDSCTNCQGNQP | 341 | Q13772 | |
| SCTNCQGNQPKGVEI | 346 | Q13772 | |
| PNAICGICLKGKESN | 376 | Q8WUB8 | |
| KNCSAACPGLQLSNN | 641 | P05107 | |
| VDKKVCSSNPCQNGG | 131 | O60494 | |
| PVGNKCNNCLAIPIT | 661 | Q7L622 | |
| EPCKNGGICTDLVAN | 126 | O43854 | |
| KDNPCGRGQCLITQS | 116 | Q14520 | |
| TGVAPQDQCKLTCQA | 611 | O75173 | |
| SKCVQGILQCDPGTI | 2301 | Q9C0G6 | |
| QTEAPFGCQCQLSGK | 201 | Q9C0K0 | |
| VTLCGSLKGCSNKSP | 291 | Q9H799 | |
| CPTCQTSYGIQKGNQ | 596 | Q8TDB6 | |
| LLKNFCGNCQASVPG | 691 | Q14993 | |
| CGNCQASVPGLKSNK | 696 | Q14993 | |
| CQPSGGILSCVNKDP | 2831 | Q9Y6R7 | |
| LNPNICLSGTCENTK | 1286 | P35555 | |
| QELPGLCQGGKCINT | 1611 | P35555 | |
| SVGNPCGNGTCKNVI | 2171 | P35555 | |
| QTKPGICENGRCLNT | 2296 | P35555 | |
| DINLCGSKGICQNTP | 2531 | P35555 | |
| LFQNPKQICSCDGLT | 236 | O14618 | |
| CFSPQQENGKQLLCG | 256 | Q9Y5Q5 | |
| LCASGICIPGKLQCN | 276 | Q9Y5Q5 | |
| EKNETLGGTCLNVGC | 71 | P09622 | |
| DPQSSCLGGECKNTV | 1141 | Q14767 | |
| GSEICKEGKCVNTQP | 1001 | Q9NS15 | |
| KSPCGNQANVLCISR | 31 | A6NJ69 | |
| SISCPSGKQCQQALL | 21 | Q17R55 | |
| GGKNCKISSVQPICL | 1391 | Q9Y4K1 | |
| GKNCIDTNECVALPG | 2011 | P35556 | |
| GSQPSLCGAKGICQN | 2576 | P35556 | |
| ETSPCQNQGKCKDGL | 91 | P00742 | |
| SVICNQLGCPTAIKA | 86 | Q86VB7 | |
| AVACKQLGCPTAVTA | 301 | Q86VB7 | |
| CQQLKCGVALSTPGG | 621 | Q86VB7 | |
| AGQVLQDSKCVACGP | 621 | Q8IWY4 | |
| TPKVCQFGALCSLQG | 3986 | Q9NZJ4 | |
| LVVSTGLCKPCGQLN | 466 | P78385 | |
| TCPAGFQLLDQKTCG | 361 | Q14114 | |
| LPSQDACQKALGTCG | 236 | Q8NGJ2 | |
| SNPGNCSCLTFLIKE | 281 | P33402 | |
| PACSGANICQVKPND | 2186 | P11717 | |
| CIEGSQGCENPKPSL | 131 | Q9UJJ7 | |
| PCNCDKTGTINGSLL | 846 | O75445 | |
| CNKSTGQCPCKLGVT | 861 | O75445 | |
| TELIPKSQKCCNGVG | 3361 | O75445 | |
| ACRNPGKNGLSNSCI | 846 | O14607 | |
| KDLLVNGCCNVNVPS | 96 | Q9H741 | |
| GQPCELNIAKAGSCV | 276 | Q3ZLR7 | |
| VQSCPGSLSLCAGVK | 1026 | Q9UQ35 | |
| ASSPCQNGGSCKDQL | 111 | P08709 | |
| LETGLCDCKPNVTGQ | 916 | P25391 | |
| GNCLGSGVLNVSICK | 316 | Q14108 | |
| PKGLCVLCPNSNNSL | 141 | Q5MNZ6 | |
| KGSLEVNCSTTCNQP | 41 | P13598 | |
| QSVSKLNQGKPCTCI | 186 | Q9NX31 | |
| GQPCELNITKAGSCV | 276 | P0C7V6 | |
| QPSNAILKTCVKAGC | 156 | P32247 | |
| APLAASCGLLTCKNQ | 126 | P78543 | |
| CLECKNAAGQTPLTI | 266 | A6NFN9 | |
| LASCNKSCGTNPDGI | 51 | Q6P4Q7 | |
| NLPSCLLCTVCKSGQ | 111 | Q9UBN6 | |
| LSSPCKNNGTCTQDP | 921 | O75094 | |
| CGCVKPALETGNLLT | 16 | Q9BU70 | |
| CTGSSKKPPNCQGTQ | 836 | A4D1E1 | |
| AGKITCLCQVPQNAA | 896 | P49588 | |
| SLPTGINAQQKLSGC | 1281 | O60673 | |
| GLCAGCVNLSKSASP | 1091 | Q96K83 | |
| LGTPCQQRCKNSIGS | 186 | Q96DN2 | |
| AKSTCSCPDLQPNGQ | 56 | O43847 | |
| SCPSCNGLADGNKLL | 1216 | Q6N022 | |
| CSLLAQCSVSPKGQA | 241 | Q9NY15 | |
| ICIQENPGSGQCEKL | 226 | Q8N883 | |
| IGGLQDQECIPCTKQ | 96 | Q9HAV5 | |
| GQCPGTCFQESSTLK | 1236 | Q6BDS2 | |
| GQSVQKIACTTLCPV | 301 | O95185 | |
| KSLGTCQDCKVQGPN | 56 | Q8TEY7 | |
| QNPGICSQICINLKG | 401 | P98155 | |
| VLEGGPCQLSCNVKA | 491 | Q9NR99 | |
| PGKVCGSNLLSICKT | 216 | P60201 | |
| CKGLSQPTTNLVAGC | 166 | Q96NK8 |